A Phase I/II Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma

Conditions: Multiple Myeloma Interventions: Biological: GC012F Sponsors: Gracell Biotechnologies Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials